Clinical Trial Update: Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver Mutations [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 umbrella trial of adjuvant therapies for completely resected high-risk stage IA-IB non-small cell lung cancer, fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: NOT_YET_RECRUITING